| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | EVP Clinical Operations
1 company
Gupta Suneel is a Chief Development Officer at Protagonist Therapeutics, Inc. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $32.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Development Officer | Sale+OE | 122,628 | $45.96 | $5,635,429.98 | -19.0% | -19.7% | +100.9% | |
| Jan 9, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Development Officer | Sale+OE | 5,000 | $25.00 | $125,000.00 | -2.6% | +10.6% | +48.2% | |
| Dec 3, 2019 | PTGX Protagonist Therapeutics, Inc | EVP Clinical Operations | Buy | 30,000 | $5.13 | $153,900.00 | +153.8% | - | - |